Matinas BioPharma Holdings (MTNB) EBT Margin (QoQ) (2015 - 2023)
Matinas BioPharma Holdings (MTNB) EBT Margin (QoQ) (2015 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.00 Bn | 132.14 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.31 Bn | 78.32 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.24 Bn | 60.06 Bn | 1.37 Bn |
| 4 | Moderna | 62.41 Bn | 57.27 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.25 Bn | 37.15 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.18 Bn | 27.88 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.93 Bn | 10.54 Bn | 668.28 Mn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.28 Bn | 26.44 Bn | - |
| 10 | Matinas BioPharma Holdings | 1.22 Mn | 406,176.27 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 77,833.00 |
| Mar 31, 2023 | 197,372.00 |
| Dec 31, 2022 | -272,023.00 |
| Sep 30, 2022 | 4,412.00 |
| Mar 31, 2021 | -7.29 Mn |
| Dec 31, 2020 | 5.63 Mn |
| Jun 30, 2018 | 1.15 Mn |
| Mar 31, 2018 | -573,563.00 |
| Dec 31, 2017 | 610,661.00 |
| Sep 30, 2017 | 794,550.00 |
| Jun 30, 2017 | 11.18 Mn |
| Sep 30, 2015 | -6,107.00 |
| Jun 30, 2015 | 147,036.00 |